obesity drug news today glp-1 2025 oct 27 Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine New oral GLP-1 drug delivers

Secondly, we combined data from trials that varied in duration, baseline characteristics, and types of AOMs, which might result in heterogeneity to the meta-analysis, so we used a random-effects model for statistical analysis

Always consult your healthcare provider

In 2018, a 39 amino-acid peptide tirzepatide (LY3298176) was developed, which is similar in size to both GLP-1 and GIP with exenatide-derived C-terminal tail and thus has a prolonged half-life

The FAERS database has become the most widely used ADR database in recent years

CARLAT VERDICT Perform a baseline risk assessment for antipsychotic-induced weight gain, and discuss lifestyle modifications with every patient

The impact on glycaemic management is most significant for diabetics (either type 1 or 2) who require insulin given most of the carbohydrates in clear fluids are simple sugars